Research

Paper

TESTING March 17, 2026

HistoAtlas: A Pan-Cancer Morphology Atlas Linking Histomics to Molecular Programs and Clinical Outcomes

Authors

Pierre-Antoine Bannier

Abstract

We present HistoAtlas, a pan-cancer computational atlas that extracts 38 interpretable histomic features from 6,745 diagnostic H&E slides across 21 TCGA cancer types and systematically links every feature to survival, gene expression, somatic mutations, and immune subtypes. All associations are covariate-adjusted, multiple-testing corrected, and classified into evidence-strength tiers. The atlas recovers known biology, from immune infiltration and prognosis to proliferation and kinase signaling, while uncovering compartment-specific immune signals and morphological subtypes with divergent outcomes. Every result is spatially traceable to tissue compartments and individual cells, statistically calibrated, and openly queryable. HistoAtlas enables systematic, large-scale biomarker discovery from routine H&E without specialized staining or sequencing. Data and an interactive web atlas are freely available at https://histoatlas.com .

Metadata

arXiv ID: 2603.16587
Provider: ARXIV
Primary Category: q-bio.QM
Published: 2026-03-17
Fetched: 2026-03-18 06:02

Related papers

Raw Data (Debug)
{
  "raw_xml": "<entry>\n    <id>http://arxiv.org/abs/2603.16587v1</id>\n    <title>HistoAtlas: A Pan-Cancer Morphology Atlas Linking Histomics to Molecular Programs and Clinical Outcomes</title>\n    <updated>2026-03-17T14:36:07Z</updated>\n    <link href='https://arxiv.org/abs/2603.16587v1' rel='alternate' type='text/html'/>\n    <link href='https://arxiv.org/pdf/2603.16587v1' rel='related' title='pdf' type='application/pdf'/>\n    <summary>We present HistoAtlas, a pan-cancer computational atlas that extracts 38 interpretable histomic features from 6,745 diagnostic H&amp;E slides across 21 TCGA cancer types and systematically links every feature to survival, gene expression, somatic mutations, and immune subtypes. All associations are covariate-adjusted, multiple-testing corrected, and classified into evidence-strength tiers. The atlas recovers known biology, from immune infiltration and prognosis to proliferation and kinase signaling, while uncovering compartment-specific immune signals and morphological subtypes with divergent outcomes. Every result is spatially traceable to tissue compartments and individual cells, statistically calibrated, and openly queryable. HistoAtlas enables systematic, large-scale biomarker discovery from routine H&amp;E without specialized staining or sequencing. Data and an interactive web atlas are freely available at https://histoatlas.com .</summary>\n    <category scheme='http://arxiv.org/schemas/atom' term='q-bio.QM'/>\n    <category scheme='http://arxiv.org/schemas/atom' term='cs.CV'/>\n    <category scheme='http://arxiv.org/schemas/atom' term='eess.IV'/>\n    <published>2026-03-17T14:36:07Z</published>\n    <arxiv:primary_category term='q-bio.QM'/>\n    <author>\n      <name>Pierre-Antoine Bannier</name>\n    </author>\n  </entry>"
}